Annonce

Log ud Log ind
Log ud Log ind

Swissquote: Cisco Rapporterer Højere Indtjening, Skuffer med Forsigtige Prognoser

Oscar M. Stefansen

torsdag 14. august 2025 kl. 9:09

Resume af teksten:

Cisco oplevede en stigning i fjerde kvartalsindkomst til 2,8 milliarder USD, drevet af øget efterspørgsel efter deres AI-produkter. Indtjeningen på 99 cent pr. aktie slog analytikernes forventninger på 98 cent, mens omsætningen nåede 14,7 milliarder USD. AI-infrastrukturordrer nåede 800 millioner USD, hvilket lover en stor vækstmulighed. På trods af positive resultater faldt aktien med 2,3% i eftermarkedet på grund af en moderat salgsprognose.

Det schweiziske aktiemarked lukkede positivt, med SMI-indekset op 0,78%. Amrize steg næsten 6% og meddelte et partnerskab med Meta Platforms. Straumann Holding faldt over 8% på grund af indtjening under forventningerne. Enkelte virksomheder som Lonza og Nestle sluttede højere, mens ABB og Geberit faldt.

I Europa steg aktier på større optimisme om rentenedsættelser fra Federal Reserve. Stoxx 600 steg 0,54%, med flere europæiske markeder i grønne tal. Beazley plc oplevede et fald på 12% på grund af lavere indtjeningsprognoser. I USA blev nye rekorder sat for Nasdaq og S&P 500 efter optimisme fra inflationstal, og boligaktier viste stærke præstationer, mens japanske aktier faldt 1,5% efter to rekordhøje slutninger.

Fra Swissquote:

Topic of the day

Cisco reported higher fourth-quarter earnings and revenue that beat analysts’ expectations, fueled by growing demand for its AI products. The tech company reported net income of $2.8 billion, or 71 cents a share, up from $2.2 billion, or 54 cents, in the year prior. Adjusted earnings were 99 cents a share. Analysts expected 98 cents, according to FactSet. Revenue was $14.7 billion, up from $13.64 billion the previous year. Wall Street predicted $14.62 billion. AI infrastructure orders exceeded $800 million, bringing the fiscal year 2025 total to $2 billion. “The AI infrastructure orders we received from webscale customers in fiscal 2025 were more than double our original target, indicating a massive opportunity ahead as we lead the required architectural shift and build the critical infrastructure needed for the AI era,” said CEO Chuck Robbins. However, the company’s sales forecast for the current fiscal year was “only” in line with expectations, as market participants noted. The stock subsequently fell by 2.3 percent in initial after-hours trading in the US.

Swiss stocks

The Switzerland market closed on a firm note on Wednesday, despite struggling for support mid way through the day’s trading session. Investors largely made their moves, reacting to the most recent earnings updates. The benchmark SMI, which stayed above the flat line the entire duration of the session, settled with a gain of 92.44 points or 0.78% at 11,978.85, near the day’s high. Amrize climbed nearly 6%. Amrize is reportedly entering a partnership with Meta Platforms aimed at engineering a highly optimized AI-driven concrete mix. Schindler Ps, Zurich Insurance, Novartis, Roche Holding, Richemont, Alcon and Swiss Re gained 1 to 1.5%. Lonza Group, Nestle, SGS and Swiss Life Holding closed higher by 0.3 to 0.9%. Straumann Holding tumbled more than 8% as its first-half earnings fell below expectations. The dental implant maker reported EBIT of 358 million francs in the first half, slightly less than the expected earnings of 365 million francs. VAT Group, Partners Group and Givaudan lost 0.9 to 1.22%. ABB, Adecco, Sika and Geberit also closed weak.

International markets

Europe

European stocks closed mostly higher on Wednesday on rising optimism about a rate cut by the Federal Reserve in September, and easing trade and geopolitical tensions. Gains were somewhat modest in several markets and traders chose to stay cautious at higher levels, choosing to wait for more economic data, and news from the tariff front. The pan European Stoxx 600 climbed 0.54%. The U.K.’s FTSE 100 gained 0.19%, while Germany’s DAX and France’s CAC 40 closed up by 0.67% and 0.66%, respectively. Switzerland’s SMI advanced 0.78%. Among other markets in Europe, Belgium, Czech Republic, Denmark, Greece, Iceland, Ireland, Netherlands, Norway, Spain and Sweden closed higher. Austria, Finland and Portugal edged up marginally. Poland and Russia ended weak, while Turkiye closed flat. In the UK market, AstraZeneca climbed about 3.25%. Spirax Group gained 3%, extending previous session’s upmove. GSK, Convatec Group, Unilever, Antofagasta, BT Group, Croda International, Hikma Pharmaceuticals, Associated British Foods, JD Sports Fashion, Haleon, WPP, Informa, Natwest Group, Next and Ashtead Group also closed notably higher. Beazley tanked more than 12% after the insurer cut its full-year premium growth forecast. The company has revised its growth guidance to low-to-mid single digits to reflect prevailing market conditions. The company reported profit before tax of $502.5 million in the first half of 2025 down from $728.9 million in the prior year. Profit after tax for the period declined to $420.3 million or 65.4 cents per share from $571.6 million or 84.8 cents per share in the previous year. Entain, St. James’s Place, British American Tobacco, Coca-Cola Europacific Partners, Fresnillo, BP, Standard Chartered, Diageo, Weir Group and Melrose Industries lost 1 to 2.5%. Persimmon closed lower by about 0.6%. The housebuilding company reported that its profit attributable to equity holders of the parent for the first half of 2025 declined to 100.0 million pounds or 30.9 pence per share from 110.7 million pounds or 34.3 pence per share in the previous year.In the German market, Bayer, Fresenius and SAP gained 3 to 3.3%. Fresenius Medical Care climbed nearly 3%.

United States

After initially extending the rally seen during Tuesday’s session, stocks gave back ground over the course of the trading day on Wednesday but managed to close mostly higher. Despite pulling back well off their highs of the session, the Nasdaq and the S&P 500 still reached new record closing highs. The Nasdaq inched up 31.24 points or 0.1 percent to 21,713.14 and the S&P 500 rose 20.82 points or 0.3 percent to 6,466.58, while the narrower Dow posted a more significant gain, jumping 463.66 points or 1.0 percent to 44,922.27. The stronger gain by the blue chip index came amid notable gains by Dow components UnitedHealth (UNH), Nike (NKE), Sherwin-Williams (SHW) and Merck (MRK). The early strength on Wall Street came as stocks continued to benefit from optimism about an interest rate cut by the Federal Reserve following yesterday’s consumer price inflation data. With the consumer price inflation data largely coming in line with economist estimates, the Fed is widely expected to lower rates by a least a quarter point next month. Housing stocks turned in some of the market’s best performances on the day, with the Philadelphia Housing Sector Index surging by 3.7 percent to its best closing level in eight months. Substantial strength was also visible among biotechnology stocks, as reflected by the 3.0 percent jump by the NYSE Arca Biotechnology Index. The gain lifted the index to a five-month closing high. Airline, pharmaceutical and computer hardware stocks also saw considerable strength, while brokerage and software stocks showed notable moves to the downside.

Asia

While the stock market in Japan is experiencing a more pronounced correction after two consecutive record highs, other stock markets in the region and in Australia are showing smaller movements in both directions. The Nikkei 225 index in Tokyo fell 1.5 per cent to 42,634 points.

Bonds

In the U.S. bond market, treasuries saw notable strength following the modest pullback seen in the previous session. Subsequently, the yield on the benchmark ten-year note, which moves opposite of its price, slid 5.5 basis points to 4.238 percent.

Analysis

JPMorgan raises Euronext target to EUR 149 (143) – Neutral

JPMorgan raises Gea target to EUR 55 (49) – Underweight

UBS lowers the Schott Pharma target to EUR 28.80 (29.20) – Buy

Hurtige nyheder er stadig i beta-fasen, og fejl kan derfor forekomme.

Få dagens vigtigste
økonominyheder hver dag kl. 12

Bliv opdateret på aktiemarkedets bevægelser, skarpe indsigter
og nyeste tendenser fra Økonomisk Ugebrev – helt gratis.

Jeg giver samtykke til, at I sender mig mails med de seneste historier fra Økonomisk Ugebrev.  Lejlighedsvis må I gerne sende mig gode tilbud og information om events. Samtidig accepterer jeg ØU’s Privatlivspolitik. Du kan til enhver tid afmelde dig med et enkelt klik.

[postviewcount]

Jobannoncer

Økonomi- og administrationschef til Søfartsstyrelsens Administrationssekretariat
Region Sjælland
Dansk Sygeplejeråd søger regnskabskonsulent med erfaring i regnskabsprocessen fra A-Z
Region Hovedstaden
Vi søger to studentermedhjælpere til Dansk Sygeplejeråds Økonomiafdeling
Region Hovedstaden
Contract manager til Finans Danmark
Region Hovedstaden
Rigspolitiet søger en administrationschef til Bornholms Politi
Bornholms Regionskommune
Dansk Erhverv søger skattepolitisk fagchef
Regiopn Hovedstaden
Strategisk Finans Partner i Forca
Region Hovedstaden
Finance Manager
Region Syddanmark
Financial Controller
Region Nordjylland
Er du vores nye regnskabscontroller i Team Regnskab Erhvervsstyrelsen?
Region Hovedstaden

Log ind

Har du ikke allerede en bruger? Opret dig her.

FÅ VORES STORE NYTÅRSUDGAVE AF FORMUE

Her er de 10 bedste aktier i 2022

Tilbuddet udløber om:
dage
timer
min.
sek.

Analyse af og prognoser for Fixed Income (statsrenter og realkreditrenter)

Direkte adgang til opdaterede analyser fra toneangivende finanshuse:

Goldman Sachs

Fidelity

Danske Bank

Morgan Stanley

ABN Amro

Jyske Bank

UBS

SEB

Natixis

Handelsbanken

Merril Lynch 

Direkte adgang til realkreditinstitutternes renteprognoser:

Nykredit

Realkredit Danmark

Nordea

Analyse og prognoser for kort rente, samt for centralbankernes politikker

Links:

RBC

Capital Economics

Yardeni – Central Bank Balance Sheet 

Investing.com: FED Watch Monitor Tool

Nordea

Scotiabank